Notably, higher counts of c-FOXP3+E-Cadherin− cells correlated with poorer prognosis, lower tumor differentiation, lymph node metastasis, and vascular invasion in pancreatic ductal adenocarcinoma (PDAC). This evidence concerns the gene FOXP3 and neoplasm.